Donald Trump has had a stroke, a prominent clinical professor of medicine said, listing evidence he said he saw in the ...

Pregnant patients with prior ischemic stroke had significantly higher odds of ischemic stroke during pregnancy and the ...

Treatment with denosumab vs oral bisphosphonates was associated with increased risks for MACE and hypocalcemia in dialysis-dependent patients with osteoporosis.

Stroke is one of the leading causes of death and disability. If patients develop a complication in the first days after stroke, such as fever or a pneumonia, their recovery is often worse and the risk ...

The CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study ...

Novo Nordisk announced today that Health Canada has approved RYBELSUS® (semaglutide tablets) to reduce the risk of major ...

A new UCLA study reveals that a widely used federal hospital safety metric is fundamentally flawed when applied to emergency ...

A case report describes mechanical thrombectomy performed 28 hours after stroke onset, guided by CT perfusion showing salvageable tissue, with marked neurologic recovery at discharge.

Celebrating Scientific Advancement Amarin applauds the groundbreaking work addressing sHTG and rare genetic disorders such as familial chylomicronemia syndrome (FCS). These advances help drive patient ...

Tirzepatide is noninferior to dulaglutide regarding composite of death from CV causes, myocardial infarction, or stroke.

For women with severe CAD, percutaneous coronary intervention is associated with increased risk for MACCE and all-cause mortality compared with CABG.